Skip to main content
. 2015 May 5;29(6):485–509. doi: 10.1007/s10822-015-9846-3

Fig. 1.

Fig. 1

The structural information available about CDK2 inhibitors prior to July 2003: all 42 protein structures shown with five small ligands in the active site (top); all 42 ligands oriented with their hinge-binding moieties upward (bottom left); and all 42 ligands with the viewpoint from the kinase hinge (bottom right)